Business Context and Reporting Period
This Form 8-K was filed by Alnylam Pharmaceuticals, Inc. on February 3, 2015. The report addresses corporate governance matters regarding the scheduling of the 2015 Annual Meeting of Stockholders and the associated deadlines for shareholder nominations.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report on a specific corporate event and does not contain financial statements or performance metrics.
Material Changes
The primary material change disclosed is the advancement of the 2015 Annual Meeting date. The meeting is now scheduled for May 1, 2015, which is more than 30 days prior to the anniversary of the 2014 Annual Meeting. Consequently, the record date for determining stockholders entitled to vote is set for the close of business on March 4, 2015.
Guidance, Outlook, and Management Commentary
- Proxy Materials: The Company intends to make proxy materials available to stockholders beginning on or about March 13, 2015.
- Shareholder Nominations: In accordance with the Company's Amended and Restated Bylaws, stockholders wishing to nominate directors or present other matters must provide written notice to the Corporate Secretary.
- Deadline: The deadline for receiving such notice is the close of business on February 13, 2015.
- Address: Notices must be sent to 300 Third Street, Cambridge, Massachusetts 02142.
Key Facts for Investor Verification
- Verify the May 1, 2015 date for the 2015 Annual Meeting of Stockholders.
- Confirm the March 4, 2015 record date for voting eligibility.
- Note the strict February 13, 2015 deadline for submitting shareholder nominations or proposals.
- Expect proxy materials to be distributed around March 13, 2015.